Cargando…
Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
Fungal infections represent a serious global health problem, causing damage to health and the economy on the scale of millions. Although vaccines are the most effective therapeutic approach used to combat infectious agents, at the moment, no fungal vaccine has been approved for use in humans. Howeve...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301004/ https://www.ncbi.nlm.nih.gov/pubmed/37367569 http://dx.doi.org/10.3390/jof9060633 |
_version_ | 1785064709926420480 |
---|---|
author | Inácio, Moisés Morais Moreira, André Luís Elias Cruz-Leite, Vanessa Rafaela Milhomem Mattos, Karine Silva, Lana O’Hara Souza Venturini, James Ruiz, Orville Hernandez Ribeiro-Dias, Fátima Weber, Simone Schneider Soares, Célia Maria de Almeida Borges, Clayton Luiz |
author_facet | Inácio, Moisés Morais Moreira, André Luís Elias Cruz-Leite, Vanessa Rafaela Milhomem Mattos, Karine Silva, Lana O’Hara Souza Venturini, James Ruiz, Orville Hernandez Ribeiro-Dias, Fátima Weber, Simone Schneider Soares, Célia Maria de Almeida Borges, Clayton Luiz |
author_sort | Inácio, Moisés Morais |
collection | PubMed |
description | Fungal infections represent a serious global health problem, causing damage to health and the economy on the scale of millions. Although vaccines are the most effective therapeutic approach used to combat infectious agents, at the moment, no fungal vaccine has been approved for use in humans. However, the scientific community has been working hard to overcome this challenge. In this sense, we aim to describe here an update on the development of fungal vaccines and the progress of methodological and experimental immunotherapies against fungal infections. In addition, advances in immunoinformatic tools are described as an important aid by which to overcome the difficulty of achieving success in fungal vaccine development. In silico approaches are great options for the most important and difficult questions regarding the attainment of an efficient fungal vaccine. Here, we suggest how bioinformatic tools could contribute, considering the main challenges, to an effective fungal vaccine. |
format | Online Article Text |
id | pubmed-10301004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103010042023-06-29 Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics Inácio, Moisés Morais Moreira, André Luís Elias Cruz-Leite, Vanessa Rafaela Milhomem Mattos, Karine Silva, Lana O’Hara Souza Venturini, James Ruiz, Orville Hernandez Ribeiro-Dias, Fátima Weber, Simone Schneider Soares, Célia Maria de Almeida Borges, Clayton Luiz J Fungi (Basel) Review Fungal infections represent a serious global health problem, causing damage to health and the economy on the scale of millions. Although vaccines are the most effective therapeutic approach used to combat infectious agents, at the moment, no fungal vaccine has been approved for use in humans. However, the scientific community has been working hard to overcome this challenge. In this sense, we aim to describe here an update on the development of fungal vaccines and the progress of methodological and experimental immunotherapies against fungal infections. In addition, advances in immunoinformatic tools are described as an important aid by which to overcome the difficulty of achieving success in fungal vaccine development. In silico approaches are great options for the most important and difficult questions regarding the attainment of an efficient fungal vaccine. Here, we suggest how bioinformatic tools could contribute, considering the main challenges, to an effective fungal vaccine. MDPI 2023-05-31 /pmc/articles/PMC10301004/ /pubmed/37367569 http://dx.doi.org/10.3390/jof9060633 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Inácio, Moisés Morais Moreira, André Luís Elias Cruz-Leite, Vanessa Rafaela Milhomem Mattos, Karine Silva, Lana O’Hara Souza Venturini, James Ruiz, Orville Hernandez Ribeiro-Dias, Fátima Weber, Simone Schneider Soares, Célia Maria de Almeida Borges, Clayton Luiz Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics |
title | Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics |
title_full | Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics |
title_fullStr | Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics |
title_full_unstemmed | Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics |
title_short | Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics |
title_sort | fungal vaccine development: state of the art and perspectives using immunoinformatics |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301004/ https://www.ncbi.nlm.nih.gov/pubmed/37367569 http://dx.doi.org/10.3390/jof9060633 |
work_keys_str_mv | AT inaciomoisesmorais fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT moreiraandreluiselias fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT cruzleitevanessarafaelamilhomem fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT mattoskarine fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT silvalanaoharasouza fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT venturinijames fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT ruizorvillehernandez fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT ribeirodiasfatima fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT webersimoneschneider fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT soaresceliamariadealmeida fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics AT borgesclaytonluiz fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics |